Gene: ST8SIA4
Official Full Name: ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4provided by HGNC
Gene Summary: The protein encoded by this gene catalyzes the polycondensation of alpha-2,8-linked sialic acid required for the synthesis of polysialic acid, a modulator of the adhesive properties of neural cell adhesion molecule (NCAM1). The encoded protein, which is a member of glycosyltransferase family 29, is a type II membrane protein that may be present in the Golgi apparatus. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34399 | ST8SIA4 Knockout cell line (A549) | Human | ST8SIA4 | 1:3~1:4 | Negative | Online Inquiry |
ST8SIA4 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to investigate the role of the ST8SIA4 gene, which encodes for a sialyltransferase involved in the biosynthesis of sialic acids on cell surfaces. These knockout cell lines exhibit a complete loss of ST8SIA4 expression, enabling researchers to study the physiological and pathological roles of sialylation processes in various biological systems.
The primary function of these knockout cell lines is to facilitate the delineation of pathways associated with sialylation, which plays critical roles in cellular interactions, immune evasion, and tumor progression. By eliminating ST8SIA4, researchers can observe changes in cellular behavior, signaling pathways, and interactions with other cells, providing invaluable insights into disease models such as cancer, autoimmune disorders, and neurodegenerative diseases.
Scientifically, ST8SIA4 Gene Knockout Cell Lines are pivotal for advancing our understanding of glycosylation's impact on cell function and overall organismal health. Their applications extend to both foundational research and clinical inquiries, where they can be leveraged to develop targeted therapies aimed at modulating sialic acid levels in pathogenic states.
Compared to traditional methods of gene silencing, such as siRNA or shRNA approaches, these knockout cell lines provide a more permanent and stable mutation, leading to reproducibility and consistency in experimental results. This stability is crucial for longitudinal studies where the effects of genetic alterations need to be assessed over time. Furthermore, our cell lines are rigorously characterized and validated to ensure specificity, providing researchers with confidence in their findings.
Incorporating ST8SIA4 Gene Knockout Cell Lines into research projects offers a powerful tool for researchers and clinicians seeking to innovate and uncover new therapeutic avenues. Our commitment to quality and innovation is underscored by our expertise in providing high-fidelity biological products tailored to meet the needs of the scientific community. By choosing our ST8SIA4 Gene Knockout Cell Lines, you are investing in reliable models that can significantly elevate your research and contribute to groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.